chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the second day of receiving the vaccine, I have pain in my arm, my nevers are tense, pain has spread to the back and down the sciatic nerve. I also have a lot of joint pain in my arm where I received the vaccine and back of my knee. I had therapy to improve the pain but it is still going on and I had to stop working because of the pain. Also, I had allergy for two weeks and lost of smell and taste, I was tested for covid and it came out negative.
migraine within 24 hours of 2nd vaccine, migraine 4 days after 2nd vaccine, migraine 5 days after 2nd vaccine
pain in lower back on the right side; sleepy; shoulder is sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in lower back on the right side), SOMNOLENCE (sleepy) and VACCINATION SITE PAIN (shoulder is sore at injection site) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008v21a and 025a21a) for COVID-19 vaccination.     Concomitant products included WARFARIN, LOSARTAN, LEVOTHYROXINE, INSULIN LISPRO (HUMALOG), METOPROLOL, ATORVASTATIN, DONEPEZIL, INSULIN DEGLUDEC (TRESIBA), VITAMIN D3, VITAMIN C [ASCORBIC ACID], ACETYLSALICYLIC ACID (ASPIRIN LOW) and ZINC for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced BACK PAIN (pain in lower back on the right side), SOMNOLENCE (sleepy) and VACCINATION SITE PAIN (shoulder is sore at injection site). At the time of the report, BACK PAIN (pain in lower back on the right side) and SOMNOLENCE (sleepy) outcome was unknown and VACCINATION SITE PAIN (shoulder is sore at injection site) was resolving.            other concomitant medications reported were insulin, hydrochlorthiazide and lactase with diary. Treatment included use of ice at injection site.
Pt recvd DTP/OPV/HIB on 8SEP92 - brought to hosp w/prelimary dx of SIDS on 12SEP92; mom stated no apparent ill effects from shots; pt heard crying a/ later in about 1 hr was found unresponsive;
These are the comments received directly from the patient: "On Friday I received the vaccine at 11:30 a.m. I woke up Saturday and felt fine, just sore at the injection sight. Later in the afternoon I had a slight headache, but very minimal. Later in the evening my right eye was red and hurt to touch, did not think much about it.  When I woke up on Sunday both my eyes were bloodshot, again did not think much about it, added some visine and went on about my day. Later in the evening they were bloodshot and watery. I called a nurse friend and talk to her she advised me to call my doctor on Monday morning. I also talked to my optometrist and she advised me if not better by Monday to call her and make an appointment for her to look. I called my primary doctor office on Monday morning and spoke to the nurse. She took my symptoms and talked to my doctor. The nurse called me back to let me know that maybe my headache caused my blood pressure to spike making my eyes irritated and watery. My vision on Monday was very foggy so I decided to call my optometrist to have her look. Her diagnosis was Primary iridocyclitis, bilateral.  This is caused from inflammation. She put me on steroids drops every 2 hours and wants me to keep my eyes dilated for at least a week so that the iris does not attach to the lens again. (it had attached but come unattached) she was concerned because my eyes are always healthy. She saw me again today, Tuesday December  22nd. My eyes are responding well to the steroids. She wants me to continue to use the steroids and dilation drops and follow up with her on Monday unless I have any complications. She also talked to Dr. for his advice on it and he also was concerned about it. Dr. said normally it affects one eye, both of my iris in each eye had attached to the lens from the inflammation. I will follow up on Monday."
Rash developed on the whole body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash developed on the whole body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced RASH (Rash developed on the whole body). At the time of the report, RASH (Rash developed on the whole body) outcome was unknown. Not Provided          Concomitant product usage were not provided. Treatment details were not provided.
made feel sicker; Initial information was received on 13-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media (under reference number US-SA-SAC20211217000525).  This case involves a patient of (unknown demographics) who experienced feel sicker (illness) when received vaccine INFLUENZA VACCINE.  The patient's vaccination included Covid vaccine. But glad got it.  The patient's medical history, past medical treatment, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious feel sicker (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment for the event.  At the time of reporting, the outcome was unknown for the event (illness).  There will be no information available on the batch number for this case.
flu; Initial information was received on 11-Feb-2021 regarding an unsolicited valid non-serious case from a patient via media.  This case involves an patient of unknown age and gender who had flu (influenza), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concomitant medication(s) were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via unknown route and site of administration for prophylactic vaccination.  On an unknown date, the patient had a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Also reported that, patient never had the flu but a few years ago Dr(doctor) said patient needed to get flu shot, patient did and one-week later patient was at doctor with the flu. No more flu shot.  No laboratory data was provided.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome was unknown.  There will be no information on the batch number for this case.; Sender's Comments: Narrative demography- patient age group is not reported in case (adult was captured to avoid EVAERS error) hence should not mention adult patient in narrative
Sick for the two days; Had period the following week and was extremely emotional and had a heavy period; Felt awful the rest of the day; Extremely emotional; Seizure; Not feeling well; Twitching my hands.; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (Seizure) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038c21a and 019b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included ETHINYLESTRADIOL, LEVONORGESTREL (VIENVA) from 15-Mar-2021 to an unknown date for Birth control, MINERALS NOS, VITAMINS NOS (ONE A DAY [MINERALS NOS;VITAMINS NOS]) from 01-May-2015 to an unknown date and COLLAGEN from 15-Mar-2021 to an unknown date for an unknown indication.   On 19-Apr-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced MALAISE (Not feeling well) and MUSCLE TWITCHING (Twitching my hands.). On 06-Jun-2021 at 2:30 PM, the patient experienced SEIZURE (Seizure) (seriousness criterion medically significant). On an unknown date, the patient experienced ILLNESS (Sick for the two days), HEAVY MENSTRUAL BLEEDING (Had period the following week and was extremely emotional and had a heavy period), FEELING ABNORMAL (Felt awful the rest of the day) and EMOTIONAL DISORDER (Extremely emotional). At the time of the report, SEIZURE (Seizure), ILLNESS (Sick for the two days), HEAVY MENSTRUAL BLEEDING (Had period the following week and was extremely emotional and had a heavy period), MALAISE (Not feeling well), MUSCLE TWITCHING (Twitching my hands.), FEELING ABNORMAL (Felt awful the rest of the day) and EMOTIONAL DISORDER (Extremely emotional) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Magnetic resonance imaging: negative (Negative) Negative.         Company Comment:  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding the event has been provided at this time.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow Up document was received and had significant information. Added Lab data. On 18-Jul-2021: Follow-up document was received and had significant information. Added vaccine facility, patient demographics, medical history, concomitant medications, event start date. Added new events like sick, heavy period, not feeling well, hand twitching, emotional.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding the event has been provided at this time.
Had my COVID booster (Pfizer) at clinic on 10/14/23. On 10/15/23 I felt headache, muscle aches, and fatigue. None of which seemed out of the ordinary. On 10/18/23 I started to feel heart palpitations and irregular heart beat. Shortness of breath and extreme fatigue on exertion. Continuing as of present 11/3/23. Have visited acute care and seen a cardiologist. Had an echocardiogram performed and result show trace mitral and tricuspid valve regurgitation. I am a 67 year old female. I exercise everyday and work in my garden also everyday. I have felt in excellent health until immediately after the COVID booster vaccine. I have had to stop my exercise regime as I am unable to do any exercise due to the onset of fatigue and palpitations whenever I try.
Headache, Myalgia, pain in joints and muscles ,chills, fatigue and headache Narrative: Symptoms started 02/27 2-4am, pain in joints and muscles, headache. 02/27 symptoms continued but improved, but noticed swollen lymph nodes and had the chills. 2/28 continued with fatigue but HA gone, continues with muscle and joint pain but improved. Arm tender and red. Employee did get shingles vaccine 3 weeks prior to 02/26 and was cleared by her PCP to get covid vaccine as scheduled.
The victim experienced  abdominal pain 3 days prior to death at hospital from septic shock cholecystits Anoxic encepathy from clotting in the lower intestine resulting in death.
"running fever 100.1-100.8"; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8734) via an unspecified route on 06Apr2021 at 12:30 (at an age of 54-years-old) in right arm as single dose for COVID-19 immunisation. The patient had no past medical history. Concomitant medication was not reported.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er6955) via an unspecified route on 16Mar2021 in left arm at 16:00, as single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. The patient did not receive other vaccination within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 06Apr2021 at 23:30, approximately 12 hours after vaccination, the patient experienced "running fever 100.1-100.8" and fever continued for 24 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures taken included TYLENOL. The clinical outcome of the event "running fever 100.1-100.8" was resolved on 07Apr2021 at 23:30.  No follow-up attempts are needed. No further information is expected.
Herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 76 year old male patient. No information was provided regarding medical history, concurrent conditions, concomitant medications, drug reactions or allergies. On or about 12-SEP-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, lot #, expiration date, route of administration and anatomical location were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced Herpes zoster. He was treated by a physician for the event. The outcome of the event herpes zoster was not reported. The reporter considered the event of herpes zoster to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
I woke up at 6 am with numbness in my left arm and hands, I went to work and it kept progressing, I took Claritin, drove home and slept for 2 days, I was totally out of it, I only got up to go to the bathroom or drink something. I was good for 24 hours then I was so fatigued slept 2 more days, I woke on the 18th I was numb, I woke up drooling, my whole left side was numb I had some drooping in my face and my boob. I did a tele med visit that morning , My doctor started me on a prednisone pack, Lymph nodes and my breast for very tender on left side. I went to see neurologist bc symptoms were not getting better and I was extremely fatigued, which is not me, I also have sever hip pain, that I never have had before. The neurologist diagnosed me Sensory deficit disorder on the left side of my body.
Multiple lesions on L shoulder (1.5 cm and .5 cm) and one lesion on L cheek (1.5 cm). Possible lesion beginning on R cheek. No other lesions noted on body. No recent illnesses.
had the vaccine and had it\ suspected vaccination failure; had it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself /herself. The age at vaccination was not reported. The patient stated he/she had Shingles vaccine and still had shingles twice. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
This is a spontaneous report from a contactable physician reporting for a patient, through a Pfizer Sales Representative. This 77 year old female patient received PREVNAR 13 intramuscular on 23Sep2013 at 0.5 ml once. Relevant medical history and concomitant medication was unknown. It was reported that on 23Sep2013 the patient was administered PREVNAR 13 and unspecified flu vaccine after which since an unknown date in 2013 the patient was not feeling well, was not able to walk and had complications in breathing. It was further reported that on 10Oct2013 the patient was hospitalized, after which since 11 or 12Oct2013 while in the hospital the patient had severe weakness on the right side of the body and lower extremities, double vision problem, and was diagnosed with Guillain-Barre syndrome. It was mentioned that the patient was still in the hospital at the time of report. Relevant laboratory data included magnetic resonance imaging (MRI), electromyography (EMG) and blood work, all on an unknown date in Oct2013 for which the results were unknown. The patient had taken PREVNAR 13 only once on 23Sep2013. Therapeutic measure taken included gamma globulin injection since an unknown date in Oct2013 at an unknown dose and frequency. The clinical outcome was unknown at the time of report.
This is a serious observational study case initially received from other health professional on 17-Jan-2019, concerning a 33-year-old adult female pregnant subject of body weight: 169 lbs, height: 623 inches and body mass index (BMI): 29.9, enrolled in a prospective observational safety study on pregnancy outcomes in women immunized with AFLURIA QIV, a seasonal quadrivalent vaccine, during pregnancy. The subject had no maternal and paternal history of major congenital malformations. The subject had no history of offspring with major congenital malformations. The subject's obstetrical history included one ectopic pregnancy and two full term live birth. The subject did not use tobacco, alcohol or illicit drugs during pregnancy. The subject's concomitant medication included Prenatal vitamins [minerals nos; vitamins nos] for pregnancy. The subject's last menstrual period (LMP) date was reported as 16-Sep-2018. On 09-Nov-2018, the ultrasound prenatal test was performed, and the results showed no congenital malformation. On 20-Nov-2018, at 09 weeks of gestational age (first trimester), the subject was administered CSL AFLURIA QIV (dose, route of administration, anatomical location, batch number and expiry date: not reported) (explicitly coded as vaccine exposure during pregnancy) for an unknown indication. On 20-Dec-2018, 1 month after vaccination, the patient had spontaneous abortion at 12.1 weeks of gestational age. At the time of this report, the outcome of the event (spontaneous abortion) was unknown. The estimated delivery date (EDD) was reported as 05-Jul-2019.; Reporter's Comments: A 33-year-old pregnant subject with medical history of one ectopic pregnancy experienced spontaneous abortion, one month after administration of AFLURIA QIV at 09 weeks of gestation (coded to Exposure during pregnancy). Despite the plausible temporal relationship between vaccination and reported event, there is no evidence for a biological mechanism that could cause the event and therefore the event was assessed as not related to the vaccination. The decision to administer a vaccine during pregnancy is related to medical decision making by the mother and her physician and is not related to any property of the medication. The event drug exposure during pregnancy was assessed as not related considering the intended use of the vaccine. The company assessed the event (spontaneous abortion) as serious (medically significant).
Large rash around the injection site; This is a spontaneous report from a contactable physician (patient). A 31-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscular (left arm) on 28Dec2020 19:00 at single dose for Covid-19 immunization. There was no medical history; no known allergies. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Dec2020, the patient experienced large rash around the injection site which lasted 7 days. There was no treatment received for the adverse event. The outcome of event was recovered on 04Jan2021. The patient has not been tested for COVID-19 since the vaccination.
Buzzing in ears and feeling of water and fullness in ears.  Have not been to Dr. as of yet.  Almost seems like a low motor sound constantly in both ears.
Within one month of receiving my second dose, my menstrual cycle returned (after not having it for over a year and a half because of an IUD).  Then my menstrual cycle began to occur every two weeks.  My resting heart rate went up over 10 BPM, I could not run at my normal pace, my VO2 max went down, I became emotional, anxious, had insomnia and felt like my hormones out of control.   After a few months of doctor's visits, it was determined that I needed a different birth control as my hormones could not be regulated.
Vaccine location : Left leg; Itching through out my body for fewdays.; This is a spontaneous report from a contactable consumer, the patient. A 64-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the leg left on 29Mar2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient did not take any concomitant medications. The patient was allergic to pet's and certain foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 00:00, the patient experienced itching throughout body for few days. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the itching. The clinical outcome of the event itching throughout body was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.